Background Interferon-beta (IFN-beta) is a commonly used treatment for multiple sclerosis (MS). Current guidelines recommend cessation of treatment during pregnancy, however the results of past studie
SGA, small for gestational age; AGA, appropriate size for gestational age; LGA, large for gestational age. * Standardized to the 2002. Percentage of singleton live births with SGA, AGA and LGA, by mat